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Abstract
Purpose Functional activation protocols are widely applied
for the study of brain-cognition relations. Only few take
advantage of the intrinsic characteristics of SPECT, particu-
larly those allowing cognitive assessment outside of the
camera, in settings close to the standard clinical or
laboratory ones. The purpose of the study was to assess
the feasibility of a split-dose activation protocol with 99mTc-
HMPAO using low irradiation dose.
Materials and methods A two-scans protocol was applied
to 12 healthy young volunteers using 270 MBq of 99mTc-
HMPAO per scan, with each image associated to a particular
experimental condition of the verbal n-back working
memory task (0-back, 2-back). Subtraction method was used
to identify regional brain activity related to the task.
Results Voxel-wise statistical analysis showed left later-
alized activity associated with the 2-back task, compared to
the 0-back task. Activated regions, mainly prefrontal and
parietal, were similar to those observed in previous fMRI
and 15O-PET studies.
Conclusion The results support the use of 99mTc-HMPAO
SPECT for the investigation of brain-cognition relations
and demonstrate the feasibility of optimal quality images
despite low radiopharmaceutical doses. The findings also
acknowledge the use of HMPAO as a radioligand to capture
neuro-energetic modulations linked to cognitive activity.
They encourage extending the application of the described
activation protocol to clinical populations.
Keywords 99mTc-HMPAO SPECT. Brain imaging .
Activation study .Working memory . Protocol validation
Introduction
In the past two decades, functional brain imaging has
become a major tool to investigate the neural bases of
cognition. The field of cognitive neuroscience has
witnessed rapid growth following the introduction of
water-labelled positron emission tomography (15O-PET)
and, more recently, functional magnetic resonance imag-
ing (fMRI). Both techniques have major advantages,
among them providing a true measure of brain metabolism
(PET) and remarkably good spatial and temporal resolu-
tions (fMRI). Furthermore, these techniques allow multi-
ple repeats of various conditions, a fact that increases the
accuracy of the data collected.
However, despite these major advantages, both PET and
fMRI require the cognitive task to be performed inside the
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scanner. The several drawbacks of this situation (uncom-
fortable supine position, noisy environment, limited “eco-
logical” assessment), may affect the participant’s behaviour
by causing interference with the ongoing cognitive activity
[1]. Additionally, participants need to remain in the scanner
throughout the whole experiment, which may be hard for
individuals who, for whatever reason, have difficulty
staying in a motion-free decubitus position for a long time.
By contrast, single photon emission computerized tomog-
raphy (SPECT) using 99mTc-HMPAO (d,l-hexamethyl
propyleneamine oxime) or 99mTc-ECD (L,L-ethylcysteinate
dimer) allows dissociation of task administration and image
acquisition. Cognitive activity occurs outside the scanner,
and the time for which participants are required to remain in
the scanner is substantially reduced, corresponding only to
the duration of image acquisition. Hence, contrary to PET or
fMRI, SPECT provides a means to measure brain regional
metabolism associated with cognitive processes while
keeping conditions close to standard laboratory ones.
Only few studies have taken advantage of SPECT for its
use with healthy young adults [2–10], although they have
provided encouraging support for the feasibility of activa-
tion protocols with 99mTc-ECD or 133Xe. To our knowl-
edge, however, only one cognitive activation study using
99mTc-HMPAO has been reported with healthy young
subjects [11]. Hence, there is a need to validate the use of
this particular radiotracer in experiments devoted to
investigate brain-cognition relations. Moreover, and given
that HMPAO uptake is closely related to neuro-energetic
mechanisms in the brain [12], it is undoubtedly an
appropriate candidate to trace differential metabolic
changes associated with cognitive activity. Another appeal-
ing advantage of 99mTc-HMPAO SPECT is its application
in the diagnosis of neurodegenerative diseases [13]. There
is evidence showing that 99mTc-HMPAO SPECT allows to
discriminate between Alzheimer’s disease (AD) on the one
hand, and frontotemporal dementia [14] or Lewy bodies
disease [15, 16] on the other hand. More, and of greater
interest to the present purpose, there is very recent evidence
showing that 99mTc-HMPAO SPECT allows to discriminate
early dysfunction associated with AD, most particularly
when the brain is under cognitive “stress”, as reached using
cognitive activation [17, 18]. Thus, not only there is a need
to validate the use of 99mTc-HMPAO SPECT for activation
studies in healthy young populations, but also to offer a
protocol easily applicable in clinical settings for inves-
tigations of various states, among which normal and
pathological aging.
Another challenge of the present study was to consider-
ably reduce the recommended 555 MBq [7, 8] or 370 MBq
[4, 5] of radioactivity to 270 MBq per scan, yet preserving
the high quality of the images. We used a 1 to 1 dose ratio
across scans as commonly applied in 99mTc SPECT
activation studies [4, 5, 7, 8], although other methods have
been proposed, such as increasing the second dose by a
factor of approximately 2.0 [19, 20]. Notably, while the
latter is meant to increase the signal to noise ratio, lowered
by the pile-up effect inherent to the split-dose protocol, the
former allows a larger reduction of the subject’s exposure to
radioactivity. Moreover, images can be post-processed
using proportional scaling to reliably grasp between-
conditions differential activities [21], despite the pile-up
effect (see the post-processing and statistical analyses
section). For all these reasons, and because of particular
radioprotection concerns, we favoured a 1 to 1 ratio
procedure.
Finally, we addressed the feasibility of the activation
protocol by convergent validity of the results. We used a
cognitive activation task, the n-back, for which a large
ensemble of comparable results has been already reported
in the neuroimaging literature [22–26]. This task is
currently one of the paradigms for which the most precise
knowledge of the underlying functional architecture is
available [27]. Replicating the findings reported both with
15O-PET and fMRI would support the validity and the
feasibility of cognitive activation studies with low-dose
99mTc-HMPAO SPECT.
Materials and methods
Subjects The population consisted of 12 healthy young
adults (10 women, 2 men), with an average age of
26.42 years (SD=2.57, range 23 to 31) and an educational
level of 20.08 years (SD=1.98, range 17 to 24). All
participants were right-handed (as assessed by the Oldfield-
Edinburgh Inventory [28]) and fluent in French. None
reported a history of medical, neurological or psychiatric
disease. The participants were recruited in the university
community by means of advertisements, and all signed
written informed consent for participation. The experiment
was approved by the ethics committees of the Geneva
University Hospitals and of the Faculty of Psychology and
Educational Sciences at the University of Geneva.
Neuropsychological procedure The verbal n-back task [26]
was administered to the participants. The subjects were
visually presented with series of letters (upper and lower
case consonants), displayed one after the other at the centre
of the computer screen. The 0-back condition, which served
as a reference, consisted in deciding whether each stimulus
corresponded to a specific target (letter “X”). The 2-back
condition consisted in deciding whether each stimulus
corresponded to the antepenultimate one in the sequence.
In each condition, 6 blocks of 36 trials were built, for a total
of 216 trials. The trial sequence was made up of a 500 ms
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stimulus display followed by a 2,500 ms fixation point (see
Fig. 1). One third of the items were selected as targets,
randomly arranged in each block. Within each condition,
block and trial order were maintained constant across
participants. The 0-back was always provided before the
2-back. The task was computerized and built using E-Prime
Software (Psychology Software Tools, Pittsburgh, PA,
USA). The script was run on a Dell (Round Rock, TX,
USA) personal computer provided with an E-Prime Serial
Response Box device and a 15-in. monitor with 640×480
pixels resolution. For each trial, time and accuracy of
responses were recorded online by the computer.
Nuclear medicine procedure Each of the two experimental
conditions of the cognitive task was associated with a
single full brain scan recording. A split-dose technique was
applied to the participants using 270 MBq (7.3 mCi) of
99mTc-HMPAO per scan. 99mTc-HMPAO was prepared
according to the recommendations of the manufacturer
(Ceretec, Amersham, UK) and intravenously injected no
longer than 20 min after preparation. Both tasks were
performed in the scanning room but outside the scanner
apparatus, providing settings close to laboratory conditions.
The participants were invited to sit comfortably in front of
the computer, with the left arm lying onto a small table. An
intravenous butterfly catheter was placed in the elbow fold
in preparation for subsequent radiopharmaceutical intrave-
nous injection. The task instructions for the 0-back
condition were provided, and the six experimental blocks
were administered. The tracer was injected at the beginning
of the third block. Due to the rapid first-pass extraction of
99mTc-HMPAO [29], brain images reflect the average
activity that was labelled during the third and fourth blocks.
At the end of the task, the participants were required to rest
during the washout period (at least 20 min, see Table 1)
before being placed in the scanner in a decubitus position.
Image acquisition lasted 30 min. The same procedure was
applied for the acquisition of the second brain image
associated with the 2-back condition. The interval between
the end of the first scan and the acquisition of the second one
was approximately 50 min. It is worth pointing out that
inherent to the split-dose single day protocol is contamina-
tion of the second scan by the remaining activity of the first
one [5, 6]. However, it has been argued that the pile-up
does not prevent the conduction of neurofunctional activa-
tion studies [4, 5, 21], particularly if post-processing
involves proportional scaling procedures. Indeed, the latter
allows statistical control for global variations in the signal
across scans and conditions [21].
Quality control procedure For each scan, quality controls
concerned the dose preparation, the effective dose admin-
istered to the subjects, the injection/acquisition delay and
the total counts obtained in the reconstructed images. For
each dose administered, the syringe radioactive content, in
MBq, was measured by means of standard laboratory
procedures. Pre- and post-injection counts were subse-
quently acquired by recording the radioactivity of the
source using the Toshiba-GCA gamma camera, calibrated
on 140 KeV. Acquisition was performed in a fixed mode
for 5 min. A region of interest (ROI) was manually drawn
around radioactive foci. To complete quality control measures,
the time between injection and acquisition was recorded.
Acquisition protocol For both scans, SPECT acquisition was
performed at least 20 min after i.v. injection using a triple
head Toshiba GCA-9300 gamma camera (Toshiba Medical
Systems, Tokyo, Japan) with a fan beam high resolution
collimation. Data were acquired on a 128×128 matrix, with a
360° rotation angle and a step-and-shoot mode (6° step angle
and 90 s rotation time), providing 60 projections.
Given that our aim was to develop a protocol that could
be easily implemented in clinical settings, and despite the
recent development of alternative methods [19], image
processing was conducted by means of methods currently
available in most commercially distributed processing
Fig. 1 Schematic representation
of the trial sequences used in the
0-back condition (left panel)
and in the 2-back condition
(right panel)
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software. These methods are routinely performed, and
have been discussed in the literature for SPECT activation
protocols [4, 5, 7, 8]. Thus, scatter correction was
performed using the TEW method [30], with 20% set
around the 140 KeV peak, and an additional 7% in the
upper and lower sides of the main window. Images were
reconstructed in a 128×128 matrix. Attenuation correction
was done by filtered back projection (Sorenson method)
using a Butterworth filter of 8.0.16 for the main window
and of 8.0.09 for the sub-windows. The attenuation
correction map was automatically drawn with a contour
set at 5%, and an attenuation coefficient set to 0.09 cm−1.
Image reconstructions used a Shepp & Logan filter in the
axial, coronal and sagittal planes with a slice thickness of
1 pixel. Voxel size was 3.44 mm3. Examples of recon-
structed images are provided in Fig. 2.
Post-processing and statistical analyses The original
Toshiba raw data files were converted into Analyze format
using MedX software (Sensor Systems, Sterling, VA,
USA). By means of SPM2 (Department of Cognitive
Neurology, Institute of Neurology, London, UK) imple-
mented in MatLab 6.5 (Math-Works, Sherborn, MA, USA),
the different images of a participant were realigned,
creating a mean volume of resliced scans. Images were
further normalized into the Talairach and Tournoux
stereotaxic space [31], using the mean images to obtain the
parameters’ values and applying to the resliced images a
trilinear interpolation with eight non-linear iterations. Co-
registration, realignment and normalization were conducted
to match each scan onto a common reference space, hence
minimizing individual differences in anatomy and allowing
subsequent voxel-wise analyses. Finally, images were
smoothed using a Gaussian filter of 10×10×12 mm3 at full
width half maximum (FWHM). Subtraction method was
applied to count densities on a voxel-by-voxel basis to
determine brain areas of significantly increased or decreased
activity. Differences in global activity between scans were
removed by scaling the activity in each voxel proportional to
the averaged global activity [21]. Grand mean values were
computed using a grey matter threshold of 0.5. This
proportional scaling procedure not only allows statistical
control for differences in global scan activity and cross-scan
activity accumulation, but also increases the sensitivity in
detecting small variation in the signal associated with the
experimental conditions. Finally, to obtain a more readily
comprehensible unit of activity, the corrected values were
adjusted around a grand mean of 50 ml/min/100 g,
corresponding to the approximated average blood flow as
measured by 15O-PET. The effect of task conditions (2-back
vs 0-back) on the count density at each voxel was estimated
using a general linear model, wherein the changes in
global counts are considered as a covariate. Linear
contrasts of the means across conditions were used on a
voxel-by-voxel basis using t statistics. The resulting sets of t
values constituted statistical parametric maps SPM(t), that
were subsequently transformed to unit normal distribution
SPM(Z) maps.
Results
Quality control Quality control values are reported in
Table 1. Of particular interest is the low inter-subject
Table 1 Quality control values, by scan and participant
Subjects Scan 1 Scan 2
Activity (MBq) % cnt red. Time (min) Scan Tcounts Activity (MBq) % cnt red. Time (min) Scan Tcounts
1 272.70 86.52 25 2,765.5 270.80 94.88 23 5,596.2
2 270.90 95.91 22 3,344.9 271.10 97.40 22 6,539.5
3 263.40 95.97 22 3,326.7 277.20 95.91 20 6,331.8
4 276.50 97.18 24 4,587.3 277.50 99.47 28 9,635.5
5 277.10 96.96 20 3,817.8 270.50 95.48 20 6,928.9
6 272.90 89.79 24 2,758.1 276.50 96.42 21 5,727.6
7 267.30 95.33 23 3,499.0 278.30 96.17 20 7,478.4
8 273.00 96.26 21 4,031.6 270.80 94.87 20 8,406.3
9 271.90 96.73 20 3,403.5 277.60 95.13 25 6,638.7
10 271.00 99.18 20 4,242.8 271.00 99.13 26 7,684.9
11 265.70 96.88 22 3,015.4 266.30 99.27 30 5,305.7
12 272.90 96.34 25 3,192.1 272.50 96.69 27 6,598.6
M 271.28 95.25 22 3,498.7 273.34 96.74 24 6,906.0
Sd 4.06 3.52 2 572.1 3.89 1.71 4 1,240.6
Counts are expressed in 10−4
Activity, Dose activity as measured by standard laboratory procedures; % cnt red., percentage reduction of counts measured in syringe after
injection; Time, time elapsed between injection and acquisition; Scan Tcounts, total number of counts in brain scan
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variability in (a) the radioactivity values collected by means
of laboratory procedures, (b) the percentage reduction in
counts post-injection and (c) the time interval between
injection and acquisition. Furthermore, these values mea-
sured for scan 1 and scan 2 were not significantly different,
as assessed by paired-samples t tests conducted on each
variable separately. All analyses yield p values larger than
0.15. Finally, it is important to stress that all images
acquired were of good quality (see Fig. 2 as an example),
and all were taken into account for further analysis.
Imaging data Inferential statistics on brain imaging data
were conducted using SPM2 (Department of Cognitive
Neurology, Institute of Neurology, London, UK). A multi-
subjects, condition, and covariates design was applied, with
two conditions (0-back, 2-back), but no behavioural
covariates. The analysis was performed without correction
for multiple comparisons, using a p value threshold of p=
0.001 and a cluster of at least 20 voxels for the peaks to be
considered. Detailed results are reported in Table 2. Given
that the sample included two men and ten women, and that
controversies exist in the literature with respect to gender
differences [32, 33], we individually compared each man’s
pattern of activity to the average pattern found in the group
of women using the method proposed by Signorini [34]. No
significant differences were found. Therefore, we pooled all
scans together to increase statistical power and report the
findings relative to the complete sample of 12 participants.
Of direct interest to the present purpose is the increased
activity specifically associated with the 2-back condition
[for the corresponding SPM(Z) maps, see Fig. 3]. The peaks
occur in an ensemble of areas involving, on the left side,
the frontopolar (BA10) and dorsolateral (BA46) regions of
the prefrontal cortex, the frontal eye field (BA8), and the
left inferior parietal lobule (BA40). Additionally to these
left-sided foci, areas of the right hemisphere demonstrated
specific activations during the 2-back task; these include
the orbitofrontal (BA11) and frontopolar (BA10) cortices as
well as the somatosensory and motor primary regions
(BA3/4) and the superior parietal lobule (BA7). Finally,
increased bilateral activity was found in the visual
association areas, mainly involving the cuneus (BA18).
Behavioural data Analysis of the behavioural data was
performed on the median response times, computed only on
correct responses and on the proportion of correct
Fig. 2 Example of raw SPECT
images of the 0-back and 2-back
conditions in the coronal and
axial planes (images are dis-
played according to the radio-
logical convention)
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responses. Scores were averaged for blocks 1 and 2, blocks
3 and 4 and blocks 5 and 6, corresponding to the events
occurring before injection and tracer uptake, during uptake
and after uptake, respectively. Descriptive statistics by
Period (before, during, after) and Condition (0-back, 2-back)
are graphically displayed in Fig. 4.
Inferential statistics were conducted using a 2×3
ANOVA design, with the Condition (0-back, 2-back) and
the Period (before, during, after uptake) as repeated
measures. With respect to the median response times,
results revealed a significant main effect of Condition F
(1,11)=22.11, p<.001, ηp
2=0.67, but the main effect of
Period, F(2,22)=0.64, p=0.54, and the Condition×Period
interaction, F(2,22)=0.80, p=0.46, were not significant. As
concerns the proportion of correct responses, a similar
pattern was observed with a significant main effect of
Condition, F(1,11)=7.28, p<.05, ηp
2=0.40, but no signif-
icant main effect of Period, F(2,22)=2.04, p=0.15, and no
significant Condition×Period interaction, F(2,22)=1.10,
p=0.35. Altogether, these results are in line with previous
findings reported in the literature [35, 36] and support the
hypothesis of an increase in cognitive demand associated
with the 2-back condition, as compared to the 0-back.
Indeed, in the former, participants take more time to
respond and demonstrate lower accuracy. It is also worth
pointing out that performance remains stable across the
three time periods, with similar patterns in both tasks.
Discussion
Findings from the present experiment using a 99mTc-
HMPAO SPECT split-dose activation protocol are rather
encouraging with respect to the two goals pursued. First,
from a technical and methodological point of view, these
results were supportive of the use of 99mTc-HMPAO as a
radiotracer labelling differences in metabolism during
cognitive activation and of the possibility of collecting
good quality brain images despite relatively low doses of
radiopharmaceuticals. Second, results regarding the local-
izations of brain activations during a verbal working
memory task were in good agreement with those reported
in the literature. Convergent validity was adequately
demonstrated, hence providing additional support for the
feasibility of cognitive activation studies with 99mTc-
HMPAO SPECT.
Concerning the behavioural data, performance was
significantly lower in the 2-back condition than in the
Fig. 3 SPM(Z) maps for the
2-back minus 0-back contrast,
displayed according to the
neurological convention
Table 2 Peak coordinates (x, y, z) of significant condition effects, with associated Z value and anatomical areas
x y z Cluster p(unc) voxel Z Voxel p(unc) BA Anatomical area
−22 38 40 0.003 4.56 0.000 BA8 Left superior frontal gyrus
−22 30 48 3.89 0.000 BA8 Left superior frontal gyrus
−30 54 0 0.002 4.42 0.000 BA10 Left superior frontal gyrus
−28 50 20 3.36 0.000 BA10 Left middle frontal gyrus
28 −30 68 0.045 4.09 0.000 BA3 Right post-central gyrus
36 −22 60 3.84 0.000 BA4 Right pre-central gyrus
−18 −92 12 0.006 3.96 0.000 BA18 Left cuneus
28 −52 48 0.021 3.89 0.000 BA7 Right superior parietal lobule
−42 −56 40 0.028 3.81 0.000 BA40 Left inferior parietal lobule
24 52 −8 0.009 3.68 0.000 BA10 Right middle frontal gyrus
36 42 −8 3.17 0.001 BA11 Right middle frontal gyrus
28 −80 8 0.085 3.53 0.000 BA18 Right cuneus
30 −80 20 3.21 0.001 BA19 Right cuneus
−44 32 16 0.076 3.49 0.000 BA46 Left middle frontal gyrus
52 −42 −4 0.045 3.45 0.000 BA37 Right middle temporal lobe
p(unc), p values uncorrected for multiple comparisons; BA, Brodmann’s area
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0-back one, which replicated previous findings [35, 36] and
supported the assumption that the 2-back was more
demanding in processing resources from the executive
component of working memory [23, 24]. Involvement of
working memory was further supported by brain imaging
results, which revealed that the 2-back condition was
associated with increased activity in left prefrontal areas
(extending to the right hemisphere), the left parietal lobule
(BA40) and bilateral occipital areas. As pointed out by
Owen et al. [27] in a recent meta-analysis of functional
imaging studies using the n-back task, the fronto-parietal
network involvement in the 2-back task is currently largely
undisputed. The fact that the major brain areas reported in
the literature using 15O-PET or fMRI were also found in the
present study strongly supports the validity of the measures
acquired with 99mTc-HMPAO SPECT, and provides good
evidence for a reliable application of the present protocol
for brain imaging experiments.
Two major issues need further discussion: the advan-
tages vs. limitations of SPECT for cognitive activation
studies, and the choice of HMPAO over ECD as ligand to
assess brain energy metabolism. Although widely applied
in clinical routine, SPECT has been rarely used for
activation studies in the field of cognitive neurosciences
compared to fMRI, or even 15O-PET. Both latter techniques
benefit from almost real-time imaging of the brain, allow
repetitions of intra-individual scan acquisitions and offer a
precise spatial resolution. However, they require a fairly
rigid experimental set-up, and the participant has to perform
the cognitive test within the scanner and remain in a
decubitus position throughout the whole experiment. Such
technical and environmental constraints not only restrict
comfort for the participant but also prevent assessment of
individuals who cannot remain still in the scanner for a long
time. Even more important is the non-negligible disruptive
impact of the fMRI noisy environment on the cognitive
processing under investigation [1]. This effect may possibly
compromise between-group comparisons, given that vari-
ous pathological states, or even advancing age, are related
to differences in the susceptibility to interfering sources of
information [37]. Hence, with respect to this particular
issue, SPECT undoubtedly demonstrates large advantages
by allowing cognitive assessment to be conducted outside
the scanner. Another major advantage of the protocol we
propose is its potential application in clinical populations,
more specifically in cases of neurodegenerative diseases.
Indeed, there is increasing evidence that 99mTc-HMPAO
SPECT permits discrimination of functional specificities
across different types of dementias [14, 15] even before
abnormalities are reported with structural imaging. Of
additional interest is very recent evidence demonstrating
that early dysfunction found in Alzheimer’s disease is best
apprehended during cognitive activation as compared to
rest [17, 18]. Hence, although 99mTc-HMPAO SPECT
might not be the most appropriate technique to investigate
the neurofunctional bases of cognition in young healthy
populations, its application might become particularly
relevant for the study of normal and pathological aging,
and the early detection of functional deficits associated with
neurodegenerative diseases.
SPECT does have several limitations. Among these are
the small number of intra-individual brain recordings and
the limited ability, due to its moderate resolution, to detect
signal differences between individuals. Although these
limitations need to be recognized, encouraging findings
already support the use of SPECT for activation studies
[4, 5, 7, 8], which should not be dismissed. Moreover,
previous studies have demonstrated that the moderate
resolution of SPECT does not prevent applying voxel-
based analyses to SPECT images, and that approaches such
as statistical parametric mapping (SPM) can adequately be
employed [2, 21], even with rather small samples [38]. The
Fig. 4 Behavioural results:
median response times
(RT, bars) and proportion of
correct responses (Pcor, lines)
before, during and after uptake,
for the 0-back and the 2-back
conditions
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findings from the present study also confirm the feasibility
of activation protocols with SPECT, despite intrinsic
limitations.
The present work is also one of the first contributions
providing a clear demonstration that SPECT can be
successfully performed with 99mTc-HMPAO in activation
experiments. To date, at least in healthy young populations,
most comparable studies exclusively used 99mTc-ECD,
probably because ECD has long been considered to reflect
regional cerebral blood flow (rCBF) better than 99mTc-
HMPAO. Recent work, however, has pointed out a cardinal
linkage between HMPAO retention dynamics and neuro-
energetic mechanisms in the brain [13, 39]. More specifi-
cally, HMPAO is prominently retained in astrocytes [12], a
cell type for which a central role in coupling neuronal
activity to glucose utilization [40] and blood flow [41] has
been demonstrated. Targeting this particular metabolic
dynamics supports favoring HMPAO over ECD to precisely
trace metabolic changes related to cognitive activity, and
particularly those associated with memory [42, 43]. In this
vein, and as already underlined earlier, the use of HMPAO
may be very helpful in tracing dysfunctions associated with
pathological processes that affect glial cells, such as
alterations of astrocyte function in degenerative diseases
[44, 45], or changes in microglia occurring in the course of
normal aging [46].
The present study provides substantial support for the
feasibility of a split-dose 99mTc-HMPAO SPECT activation
protocol and reveals its ability to identify brain regions
involved in cognitive activity. Our findings further warrant
the use of HMPAO as a radioligand. Considering the emerg-
ing role of neuron–astrocyte interactions in coupling syn-
aptic activity with metabolic and vascular responses [47],
HMPAO may be better suited than ECD to capture neuro-
energetic modulations associated with cognitive activity.
Thus, 99mTc-HMPAO SPECT activation protocols may
attract increasing interest not only in the study of neuro-
functional bases of cognition, but also, and most importantly,
in further investigations of neuro-energetic dysfunctions in
normal and pathological aging. Finally, the results broadly
support performing brain-imaging experiments in settings
close to standard clinical ones and associating low irradiation
with high-quality images. In conclusion, this empirical
validation study has shown that functional imaging studies
of cognition using 99mTc-HMPAO SPECT are both techni-
cally and methodologically feasible.
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